Tang Capital Management WGSWW Position
Exited4-Fund ConvergenceTang Capital Management exited their position in GeneDx Holdings Corp. (WGSWW) in Q1 2024, after holding the stock for 4 quarters.
The position was first reported in Q2 2023 and has been tracked across 4 quarterly 13F filings.
WGSWW is a convergence signal: 4 specialist biotech funds hold this stock, suggesting high institutional conviction.
About GeneDx Holdings Corp.
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
Full company profile →Tang Capital Management WGSWW Position History
Frequently Asked Questions
Does Tang Capital Management own WGSWW?
No. Tang Capital Management exited their position in GeneDx Holdings Corp. (WGSWW) in Q1 2024. They previously held the stock for 4 quarters.
How many hedge funds own WGSWW?
4 specialist biotech hedge funds currently hold WGSWW, including Casdin Capital, Driehaus Capital, Deerfield Management and 1 more. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Tang Capital Management first buy WGSWW?
Tang Capital Management's position in WGSWW was first reported in Q2 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Tang Capital Management's WGSWW position increasing or decreasing?
Tang Capital Management completely exited their WGSWW position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
WGSWWCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Tang Capital ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →